Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
US Department of Justice
Citi
Boehringer Ingelheim
Chubb
AstraZeneca
Medtronic
Cantor Fitzgerald
McKinsey
McKesson

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,553,479

« Back to Dashboard

Which drugs does patent 7,553,479 protect, and when does it expire?

Patent 7,553,479 protects FERAHEME and is included in one NDA.

This patent has eleven patent family members in ten countries.
Summary for Patent: 7,553,479
Title:Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof
Abstract:Compositions, methods of making the compositions, and methods of using the compositions are provided for an enhanced magnetic resonance imaging agent and a hematinic agent, the agents comprising carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides. Methods of use of the carboxymethyl reduced dextran as a plasma extender are provided.
Inventor(s): Groman; Ernest V. (Brookline, MA), Paul; Kenneth G. (Holliston, MA), Frigo; Timothy B. (Waltham, MA), Bengele; Howard (Canton, MA), Lewis; Jerome M. (Newton, MA)
Assignee: AMAG Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:10/386,394
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 7,553,479

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Amag Pharms Inc FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,553,479

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,926,947 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
6,599,498 Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives ➤ Subscribe
7,871,597 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
9,555,133 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
8,591,864 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
8,501,158 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,553,479

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Moodys
Citi
Chubb
McKinsey
Harvard Business School
Daiichi Sankyo
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot